China
-
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
Phase 3 · randomised · 582 people · 1 site in China · Recruiting now
-
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Phase 3 · randomised · 386 people · 1 site in China · Recruiting now
-
Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
Phase 3 · randomised · 160 people · 1 site in China · Recruiting now
-
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Phase 3 · randomised · 204 people · 1 site in China · Recruiting now
-
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 · randomised · 128 people · 1 site in China · Recruiting now